Episode notes
It’s World Immunization Day on Monday, so we had a chat with Geovax chairman, president and CEO David Dodd, and in our other conversation, we talked about infertility, with Igyxos Biotherapeutics’ chief medical officer Elke Bestel.
Challenging infertility
Igyxos Biotherapeutics is a French biotechnology company founded in 2017 and based in Nouzilly, France. The company focuses exclusively on infertility, developing monoclonal antibody‑based therapeutics designed to enhance the activity of gonadotropins, the hormones central to reproduction.
Its lead program involves a first‑in‑class antibody that potentiates follicle stimulating hormone (FSH), aiming to improve the effectiveness of fe ...
Keywords
biotechbiotechnologyvaccinesWorld Immunization DayinfertilityIgyxosGeovax